M. Wahiduzzaman, A. Yasmin, M. Shahriar Hossain, R. Dhar, and M. M. Haider, “Efficacy and safety of empagliflozin (SGLT2 inhibitor) in Bangladeshi patients with type 2 diabetes mellitus”, Int J Res Med Sci, vol. 13, no. 12, pp. 5150–5154, Nov. 2025.